Test Report

Pt. No : BSFH13 Location :

Patient Name : PRADYUT PAL Primary Sample : Blood
Age : 47 years Collected On : 07/04/2023, 08:30 AM
Sex : Male Received Date & Time : 08/04/2023, 08:28 AM
Organization : HAZARIBAGH Reported Date & Time : 08/04/2023, 11:34 AM
Referred By : BSF HAZARIBAGH Accession No

230980005

Test Description Result Reference Range Unit(s)

SEROLOGY

HBsAg- Australia Antigen (RAPID TEST)

Australia Antigen (HBsAg), Screening Test

Result NON REACTIVE NON REACTIVE
Method : Immunochromatography (Rapid Card Method)

HCV (RAPID TEST)

HCV Antibodies Screening Test NON-REACTIVE NON-REACTIVE

Method : Immunochromatography (Rapid Card Test)

Page 1 of 9
 Test Report
Pt. No : BSFH13 Location :
Patient Name : PRADYUT PAL Primary Sample : Blood
Age : 47 years Collected On : 07/04/2023, 08:30 AM
Sex : Male Received Date & Time : 08/04/2023, 08:28 AM
Organization : HAZARIBAGH Reported Date & Time : 08/04/2023, 11:34 AM
Referred By : BSF HAZARIBAGH Accession No

230980005

Test Description Result Reference Range Unit(s)

THYROID HORMONES

Thyroid Function Test

T3- TOTAL 0.75 0.5 - 2 ng/ml

Method : CLIA
T4- TOTAL 8.14 4.4 - 10.8 ug/dL
Method : CLIA
TSH- THYROID STIMULATING HORMONE 4.99 0.39 - 6.16 uIU/mL
Method : CLIA Newborn upto 4 days 1 - 17.6
Interpretation

* TSH stimulates the thyroid gland to produce the main thyroid hormones T3 and T4.
* In cases of hyperthyroidism TSH level is severely inhibited and may even be undetectable. In rare forms of high-origin
hyperthyroidism, the TSH level is not reduced, since the negative feedback control of the thyroid hormones has no effect.
* In cases of primary hypothyroidism, TSH levels are always much higher than normal and thyroid hormone levels are low.
*T4 assay aids in assessing thyroid function, which is characterized by a decrease in thyroxine levels in hypothyroidism and an
increase in hyperthyroidism. T3 plays an important part in maintaining euthyroidism.
* TSH, T4 & T3 determination may be associated with other tests such as FT4 & FT3 assay, as well as with the clinical examination
of the patient.

Page 2 of 9
 Test Report
Pt. No : BSFH13 Location :
Patient Name : PRADYUT PAL Primary Sample : Blood
Age : 47 years Collected On : 07/04/2023, 08:30 AM
Sex : Male Received Date & Time : 08/04/2023, 08:28 AM
Organization : HAZARIBAGH Reported Date & Time : 08/04/2023, 11:34 AM
Referred By : BSF HAZARIBAGH Accession No

230980005

Test Description Result Reference Range Unit(s)

HAEMATOLOGY

CBC(Complete Blood Count)

HAEMOGLOBIN (Colorimetric) 15.7 13.5 - 18.0 gm/dL

PLATELET COUNT (electrical impedance) 120 150 - 450 10^3/cu.mm
TOTAL WBC COUNT (electrical impedance) 6600 4000-11000 cell/cu.mm
RBC COUNT(electrical impedance) 5.07 4.7 - 6.0 mil/cu.mm
PCV/ HCT (calculated) 52.3 42 - 52 %
MCV (electrical impedance) 103.16 78 - 100 fL
MCH (calculated) 30.97 27 - 31 pg
MCHC (calculated) 30.02 32 - 36 %
RDW (calculated) 14.2 11.5 - 14.0 %
RDW-SD (calculated) 60.7 35 - 56 fL

DIFFERENTIAL COUNT (Laser based flow cytometry)

Neutrophils 51.7 40 - 80 %
Lymphocytes 37.5 20 - 40 %
Eosinophils 5.1 1-6 %
Monocytes 4.9 2 - 10 %
Basophils 0.80 1-2 %
MPV (calculated) 10.8 7.2 - 11.7 fL
PDW (calculated) 14.1 9.0 - 17.0 %
PCT (calculated) 0.13 0.108 - 0.282 %

Page 3 of 9
 Test Report
Pt. No : BSFH13 Location :
Patient Name : PRADYUT PAL Primary Sample : Blood
Age : 47 years Collected On : 07/04/2023, 08:30 AM
Sex : Male Received Date & Time : 08/04/2023, 08:28 AM
Organization : HAZARIBAGH Reported Date & Time : 08/04/2023, 11:34 AM
Referred By : BSF HAZARIBAGH Accession No

230980005

Test Description Result Reference Range Unit(s)

BIOCHEMISTRY

LIVER FUNCTION TEST

BILIRUBIN TOTAL 0.84 0 - 2.0 mg/dl

Method : Diazo
BILIRUBIN- DIRECT 0.38 Adults and Infants : 0.0 - 0.40 mg/dL
Method : Diazo Method
BILIRUBIN- INDIRECT 0.46 0.1 - 1.0 mg/dL
TOTAL PROTEIN 7.02 6.4 - 8.3 g/dL
Method : Biuret
ALBUMIN 4.82 3.5 - 5.2 g/dL
Method : BCG/ Dye method/ Doumas et al 1
GLOBULIN 2.20 1.8 - 3.6 g/dL
A/G Ratio 2.19 1.2 - 2.2
SGPT (ALT) 118.2 Men : upto 45 U/L IU/L
Method : IFCC Women : upto 34U/L
SGOT (AST) 68.5 Men : upto 35U/L IU/L
Method : IFCC Women : upto31U/L
ALKALINE PHOSPHATASE 141 30 - 120 U/L
Method : PNPP, AMP Buffer

KIDNEY FUNCTION TEST

BLOOD UREA 27.6 19 - 45 mg/dl

Method : UREASE-GLDH
BLOOD UREA NITROGEN (BUN) 12.90 7 - 18 mg/dL
Method : Calculated
CREATININE 0.8 0.7 - 1.3 mg/dl
Method : Enzymatic
URIC ACID 4.4 3.5 - 7.2 mg/dL
Method : Uricase UV
SODIUM 138.4 135 - 155 mmol/L
Method : ISE, Direct Newborn: 133-146
POTASSIUM 4.16 3.5 - 5.5 mmol/L
Method : ISE, Direct Newborn: 3.7-5.9

Page 4 of 9
 Test Report
Pt. No : BSFH13 Location :
Patient Name : PRADYUT PAL Primary Sample : Blood
Age : 47 years Collected On : 07/04/2023, 08:30 AM
Sex : Male Received Date & Time : 08/04/2023, 08:28 AM
Organization : HAZARIBAGH Reported Date & Time : 08/04/2023, 11:34 AM
Referred By : BSF HAZARIBAGH Accession No

230980005

Test Description Result Reference Range Unit(s)

CHLORIDE 101.4 95 - 105 mmol/L

Method : ISE, Direct

LIPID PROFILE

CHOLESTEROL- TOTAL 206 Desirable level | < 200 mg/dL

Method : CHOD-PAP Borderline High | 200-239
High | >or = 240
TRIGLYCERIDES 210.9 Normal: < 150 mg/dL
Method : GPO-Trinder's Borderline High: 150-199
High: 200-499
Very High: >= 500
HDL CHOLESTEROL 73.2 Male : 35.3-79.5 mg/dL
Method : Direct measure PTA/ MgCl2 Female : 42.0-88.0
LDL CHOLESTEROL 90.62 Optimal < 100 mg/dL
Method : Direct Method
VLDL CHOLESTEROL 42.18 6 - 38 mg/dL
Method : Calculated Value
TOTAL CHOL./ HDL RATIO 2.81 3.5 - 5.0
LDL/HDL RATIO 1.24 2.5 - 3.5
Note:
8-10 hours fasting sample is ideally required.

BLOOD SUGAR : Fasting

BLOOD SUGAR (FASTING) 98.4 Cord: 45-96mg/dl mg/dL

Method : GOD-POD Newborn, 1d : 40-60mg/dl
Newborn,>1d : 50-80mg/dl
Child : 60-100mg/dl
Adult : 74-100
>60y : 82-115mg/dl
>90y : 75-121mg/dl

CALCIUM

Page 5 of 9
 Test Report
Pt. No : BSFH13 Location :
Patient Name : PRADYUT PAL Primary Sample : Blood
Age : 47 years Collected On : 07/04/2023, 08:30 AM
Sex : Male Received Date & Time : 08/04/2023, 08:28 AM
Organization : HAZARIBAGH Reported Date & Time : 08/04/2023, 11:34 AM
Referred By : BSF HAZARIBAGH Accession No

230980005

Test Description Result Reference Range Unit(s)

CALCIUM 9.4 Adult : 8.60 - 10.20 mg/dL

Method : Arsenazo III Child :
2-12yrs : 8.8-10.8
10d-24months : 9.0-11.0
0-10days : 7.6-10.4

VITAMIN D3

25-OH VITAMIN D 24.72 Very Severe deficiency <5 ng/ml

Method : Elisa Severe Deficiency 5-10
Deficiency 10-30
Optimal 30-50
Upper Normal 50-70
Overdose but not toxic 70-150
Vit D Intoxication >150

VITAMIN B12

Vitamin B12 386.02 Adult: 200 - 835 pg/mL

Method : CLIA Newborn: 160 - 1300

Glycosylated Haemoglobin

HbA1c (GLYCOSYLATED HEMOGLOBIN), 5.9 %

BLOOD
Estimated Average Glucose : 122.63 - mg/dL
Interpretation
As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5

Page 6 of 9
 Test Report
Pt. No : BSFH13 Location :
Patient Name : PRADYUT PAL Primary Sample : Blood
Age : 47 years Collected On : 07/04/2023, 08:30 AM
Sex : Male Received Date & Time : 08/04/2023, 08:28 AM
Organization : HAZARIBAGH Reported Date & Time : 08/04/2023, 11:34 AM
Referred By : BSF HAZARIBAGH Accession No

230980005

Test Description Result Reference Range Unit(s)

Age > 19 years

Goal of therapy: < 7.0
Therapeutic goals for glycemic control Action suggested: > 8.0
Age < 19 years
Goal of therapy: <7.5
Comments:
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks & is a much better indicator of long term
glycemic control compared to blood & urinary glucose determinations.

Page 7 of 9
 Test Report
Pt. No : BSFH13 Location :
Patient Name : PRADYUT PAL Primary Sample : Blood
Age : 47 years Collected On : 07/04/2023, 08:30 AM
Sex : Male Received Date & Time : 08/04/2023, 08:28 AM
Organization : HAZARIBAGH Reported Date & Time : 08/04/2023, 11:34 AM
Referred By : BSF HAZARIBAGH Accession No

230980005

Test Description Result Reference Range Unit(s)

BIOCHEMISTRY

Serum Iron

IRON 140.7 60 - 160 µg/dL

Method : Ferrozine Method
METHOD Ferroine method
Limitations
Serum iron is not reliable as the primary test to identify iron deficiency or screening for Hemochromatosis and other iron overload
diseases. For these conditions, a serum TIBC, percent transferrin saturation, and ferritin assay are recommended. Diurnal variation
normal values in mid-morning, low values in mid-afternoon, very low values (~10 ug/dL) near mid- night. diurnal variation
disappears at levels <45 ug/dL. Iron dextran administration causes increase for several weeks ( may be >1000 ug/dL) Estrogenes
and oral contraceptives increased TIBC levels. Asparaginase,choramphenico,corticotropin,cortisone,and testosterone decrease the
TIBC levels.
Use

Differential diagnosis of anemias

Should always be performed whenever serum iron is done to calculate percent saturation for diagnosis of iron defeciency
Screening for iron overload.

Please correlate with clinical conditions.

Total IgE

Immunoglobulin E (IgE) 39.70 Upto 200 IU/mL

Method : CLIA
Interpretation:
The level of serum IgE rises during childhood and reaches adult levels during the teens. IgE is the mediator of the allergic
response. Patients with atopic disease, including allergic asthama, allergic rhinitis, and atopic dermatitis commonly have
moderately elevated serum IgE levels. Total serum IgE levels may also be elevated in the presence of some clinical conditions that
are not related to allergy. These clinical conditions include parasitic infections, immunodeficiency states, autoimmune diseases,
Hodgkins disease, bronchopulmonary aspergillosis, IgE myeloma, and Sezary syndrome.

**END OF REPORT**

Page 8 of 9
 Test Report
Pt. No : BSFH13 Location :
Patient Name : PRADYUT PAL Primary Sample : Blood
Age : 47 years Collected On : 07/04/2023, 08:30 AM
Sex : Male Received Date & Time : 08/04/2023, 08:28 AM
Organization : HAZARIBAGH Reported Date & Time : 08/04/2023, 11:34 AM
Referred By : BSF HAZARIBAGH Accession No

230980005

Test Description Result Reference Range Unit(s)

Page 9 of 9